MYC may be additionally involved in other processes relevant to immune-mediated tumor cytotoxicity, including inhibiting ferroptosis and necroptosis [36,37], contributing to evasion from anti-tumor immune responses via non-apoptotic mechanisms of programmed cell death. The gene discussed is MYC; the disease is neoplasm.